Melody Burcar

Melody Burcar is an experienced finance executive with a robust background in various leadership roles within the biotechnology and health sectors. Currently serving as Vice President of Finance at LENZ Therapeutics, Melody has held senior positions at Viracta Therapeutics, Inc. and Secura Bio, Inc., where responsibilities included serving as Senior Vice President Finance and VP of Finance, respectively. Prior experience also includes significant roles at Synthetic Genomics, where Melody advanced from Senior Accounting Manager to Director of Corporate Controller. Melody holds a BS in Accounting from the University of San Diego and an MBA from the Rady School of Management at the University of California, San Diego.